NASDAQ · HYPMY

Hypera S.A.

Healthcare · Drug Manufacturers - Specialty & Generic

$4.20

Down-$0.15 (-3.45%)

Updated Aug 27, 2026, 6:02 PM

SID Score

6.1/10

Composite research score

Smart Money

46/100

Neutral

Price performance

HYPMY price history

1M range · 0 trading sessions · Daily adjusted prices

Data unavailable

Market data is busy. Please try again shortly.

The latest Smart Investors Daily articles mentioning HYPMY.

The latest Smart Investors Daily articles mentioning HYPMY.

Stock researchCompany · Earnings

Company

Market Activity

Research & News

HYPMY research

Reported results, surprises, and transcripts.

HYPMY earnings history
Report date	Quarter	Year	EPS actual	EPS estimate	EPS surprise	Revenue
Aug 6, 2026	Q2	2,026	$0.138	$0.14	-0.01%	462.1M
Aug 5, 2026	Q2	2,026	—	$0.14	—	—
Apr 28, 2026	Q1	2,026	$0.104	—	—	383.21M
Apr 27, 2026	Q1	2,026	—	—	—	—
Apr 22, 2026	Q1	2,026	—	—	—	—
Mar 23, 2026	Q4	2,025	—	—	—	—
Mar 19, 2026	Q4	2,025	—	—	—	—
Mar 12, 2026	Q4	2,025	$0.132	—	—	414.4M
Sep 30, 2025	Q3	2,025	$0.72	$0.7064	+1.93%	—
Jun 30, 2025	Q2	2,025	$0.68	$0.6143	+10.70%	—
Mar 31, 2025	Q1	2,025	-$0.22	-$0.2402	+8.41%	—
Dec 31, 2024	Q4	2,024	$0.13	$0.0103	+1162.14%	—
Sep 30, 2024	Q3	2,024	$0.59	$0.549	+7.47%	—
Jun 30, 2024	Q2	2,024	$0.78	$0.7298	+6.88%	—
Mar 31, 2024	Q1	2,024	$0.62	$0.5768	+7.49%	—
Dec 31, 2023	Q4	2,023	$0.47	$0.5768	-18.52%	—
Sep 30, 2023	Q3	2,023	$0.79	$0.7828	+0.92%	—
Jun 30, 2023	Q2	2,023	$0.79	$0.7364	+7.28%	—
Mar 31, 2023	Q1	2,023	$0.53	$0.5441	-2.59%	—
Dec 31, 2022	Q4	2,022	$0.65	$0.7133	-8.87%	—

Select a published call transcript to read it on this page.

No earnings transcripts are available.